International Biotechnology Trust’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-129,700
| Closed | -$11.8M | – | 66 |
|
2023
Q2 | $11.8M | Buy |
129,700
+98,000
| +309% | +$8.92M | 3.6% | 8 |
|
2023
Q1 | $2.09M | Hold |
31,700
| – | – | 0.58% | 38 |
|
2022
Q4 | $1.64M | Buy |
+31,700
| New | +$1.64M | 0.51% | 38 |
|
2022
Q3 | – | Sell |
-1,470
| Closed | -$32.5K | – | 69 |
|
2022
Q2 | $32.5K | Sell |
1,470
-31,030
| -95% | -$686K | 0.34% | 53 |
|
2022
Q1 | $1.54M | Hold |
32,500
| – | – | 0.35% | 48 |
|
2021
Q4 | $1.54M | Buy |
+32,500
| New | +$1.54M | 0.34% | 50 |
|
2021
Q3 | – | Sell |
-23,400
| Closed | -$1.48M | – | 70 |
|
2021
Q2 | $1.48M | Hold |
23,400
| – | – | 0.39% | 45 |
|
2021
Q1 | $1M | Buy |
+23,400
| New | +$1M | 0.26% | 47 |
|